Figures & data
Table 1 Demographic characteristics of studied groups
Table 2 Parameters of patient compliance in studied groups (parameters are expressed as mean ± SD)
Figure 1 The changes in weekly number of chest pain episodes and additional short-acting nitrates taken in case of need with time in studied groups.Two initial weeks constitute baseline period.
![Figure 1 The changes in weekly number of chest pain episodes and additional short-acting nitrates taken in case of need with time in studied groups.Two initial weeks constitute baseline period.](/cms/asset/15b80e81-ab0e-4eee-8e57-eaa269abcc94/dvhr_a_32235_f0001_b.jpg)
Table 3 EQ-5D dimension scores and visual analog health scale (VAS) scores at randomization (V0) and the final visit (V8)
Table 4 Changes to the quality of life dimensions after 8 weeks of active treatment